DAFNA Capital Management’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $1.07M | Sell |
|
|||||
|
2022
Q3 | $5.96M | Sell |
|
|||||
|
2022
Q2 | $5.27M | Buy |
|
|||||
|
2022
Q1 | $5.26M | Sell |
|
|||||
|
2021
Q4 | $6.04M | Buy |
|
|||||
|
2021
Q3 | $1.91M | Buy |
|
|||||
|
2021
Q2 | $2.23M | Buy |
|
|||||
|
2021
Q1 | $1.53M | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $578K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $1.79M | Hold |
|
|||||
|
2019
Q2 | $2.51M | Buy |
|
|||||
|
2019
Q1 | $3.7M | Sell |
|
|||||
|
2018
Q4 | $2.62M | Buy |
|
|||||
|
2018
Q3 | $3.26M | Hold |
|
|||||
|
2018
Q2 | $3.95M | Sell |
|
|||||
|
2018
Q1 | $4.21M | Sell |
|
|||||
|
2017
Q4 | $3.32M | Sell |
|
|||||
|
2017
Q3 | $3.51M | Buy |
|
|||||
|
2017
Q2 | $110K | Sell |
|
|||||
|
2017
Q1 | $379K | Buy |
|